PDF-Nivolumab and
ipilimumabUV1 vaccination as 2ndline treatment in patients with malignant mesothelioma the NIPUstudyAuthors Vilde D Haakensen1 Anna Nowak2 Espen Basmo Ellingsen13
Download Presentation
"Nivolumab and" is the property of its rightful owner. Permission is granted to download and print materials on this website for personal, non-commercial use only, provided you retain all copyright notices. By downloading content from our website, you accept the terms of this agreement.
Presentation Transcript
Transcript not available.